Goodwin Procter LLP advised Relay Therapeutics, Inc. on the deal. Relay Therapeutics, Inc. (Nasdaq: RLAY) announced its collaboration and license agreement with Genentech, a member of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
